Innovative Engagement Tools BBK Worldwide's recent launch of TCN Engage demonstrates their focus on advancing patient engagement through technology, offering a compelling opportunity to upsell or integrate their ecosystem into other clinical trial networks seeking improved patient retention and support services.

Diversity and Inclusion Focus With the company's commitment to improving diversity, equity, and inclusion in clinical trials, there is potential to collaborate with organizations prioritizing diverse patient recruitment, expanding reach into underserved populations for better trial outcomes.

Recent Product Recognition Being recognized as one of the most innovative products of 2022 positions BBK as a trailblazer in clinical trial solutions, opening doors for partnership opportunities with sponsors and CROs seeking cutting-edge patient engagement technologies.

Strategic Industry Integration Since joining Publicis Health in 2022, BBK has gained a strategic advantage for cross-promotion of its services within a large network, presenting opportunities for upselling comprehensive R&D marketing and patient engagement bundles across a broader client base.

Growth Through Partnerships Collaborations with biotech and pharmaceutical companies, such as Cellectar Biosciences, highlight BBK’s capacity to offer tailored concierge services, indicating a market for expanding these personalized patient services to additional clinical trial sponsors.